•   Failure to offer treatment to CHH females seeking fertility on the basis that “their AMH level is too low”, whereas low AMH is entirely to be expected in CHH females whose ovarian granulosa cells have never been exposed to FSH. This evidence concerns the gene BRD2 and cartilage-hair hypoplasia.